in the land of allusion, page-30

Kar18na

From AGM slide

Pharma A SA 70M$/yr when ramped up.
Pharma I Teva 50M$ " " " "
JMT.

SA could put up $$$ (40-50M$) for a Unifill line and UNS lease it back. UNS can restrict SA to 30% of production that is why they may put in their own prod line.

I think we have seen enough analyst's reports to not take too much notice of them. Only probable helpful thing is they may bring in new shareholders. At the moment probably take their SP prediction and half it.